Sunday, January 21, 2018

Real Time Search

Talecris Biotherapeutics Announces Premerger HSR Filing

Carolina Headlines - Bioscience

RESEARCH TRIANGLE PARK, NC – Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR) today confirmed that it filed its premerger notification and report form with respect to its proposed merger with Grifols S.A. under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with the Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice on July 6, 2010. Grifols has informed Talecris that their company filed its premerger notification and report form the following day.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com

Source: Talecris Biotherapeutics Holdings Corp.

CONTACT: Talecris Investor Relations: Drayton Virkler, +1-919-316-2356,
This e-mail address is being protected from spambots. You need JavaScript enabled to view it ; or Talecris Corporate Communications: Becky
Levine, +1-919-316-6590,
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Web Site: http://www.talecris.com/

Market Watch


Ads on: Special HTML

Login Form